What is she best known for?
The fields of study she is best known for:
- Gene
- Cancer
- Internal medicine
Her main research concerns Ovarian cancer, Genetics, Internal medicine, Oncology and Breast cancer.
The study incorporates disciplines such as Odds ratio, Cancer research, Gynecology and Serous fluid in addition to Ovarian cancer.
Her work in Internal medicine covers topics such as Germline mutation which are related to areas like Germline, Carcinoma and MLH1.
Her research investigates the connection with Oncology and areas like Disease which intersect with concerns in Young adult, Hormone therapy and Hormone replacement therapy.
Her studies in Breast cancer integrate themes in fields like Prostate cancer, Family history and Gene mutation.
The Cancer study combines topics in areas such as Transcription, Case-control study and Loss of heterozygosity.
Her most cited work include:
- Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk (951 citations)
- Age-dependent DNA methylation of genes that are suppressed in stem cells is a hallmark of cancer (603 citations)
- Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies. (561 citations)
What are the main themes of her work throughout her whole career to date?
Susan J. Ramus spends much of her time researching Ovarian cancer, Internal medicine, Oncology, Genetics and Single-nucleotide polymorphism.
Her Ovarian cancer research is multidisciplinary, incorporating perspectives in Breast cancer, Genome-wide association study, Serous fluid and Cancer research.
Her research investigates the link between Internal medicine and topics such as Germline mutation that cross with problems in Germline.
She works mostly in the field of Oncology, limiting it down to concerns involving Odds ratio and, occasionally, Confidence interval.
Her Single-nucleotide polymorphism study combines topics in areas such as Allele and Bioinformatics.
Her Cancer research includes themes of Genetic model and Risk factor.
She most often published in these fields:
- Ovarian cancer (63.77%)
- Internal medicine (51.80%)
- Oncology (50.30%)
What were the highlights of her more recent work (between 2018-2021)?
- Internal medicine (51.80%)
- Oncology (50.30%)
- Ovarian cancer (63.77%)
In recent papers she was focusing on the following fields of study:
Her primary scientific interests are in Internal medicine, Oncology, Ovarian cancer, Breast cancer and Cancer research.
Her Internal medicine study combines topics from a wide range of disciplines, such as Genetic association and Germline.
Her Oncology study incorporates themes from Odds ratio, Germline mutation, Prostate, Ovarian carcinoma and Single-nucleotide polymorphism.
Specifically, her work in Ovarian cancer is concerned with the study of Stage IIIC.
Her work carried out in the field of Breast cancer brings together such families of science as FANCM, Fanconi anemia, CHEK2, Gene mutation and Risk factor.
She combines subjects such as Tumor heterogeneity, Human Epidermal Growth Factor Receptor 2, Susceptibility locus and Serous ovarian cancer with her study of Cancer research.
Between 2018 and 2021, her most popular works were:
- Cancer Risks Associated With Germline PALB2 Pathogenic Variants: An International Study of 524 Families (68 citations)
- Cancer Risks Associated With Germline PALB2 Pathogenic Variants: An International Study of 524 Families (68 citations)
- Shared heritability and functional enrichment across six solid cancers (41 citations)
In her most recent research, the most cited papers focused on:
Susan J. Ramus mainly focuses on Breast cancer, Internal medicine, Oncology, Cancer and Carcinoma.
Her Breast cancer research is multidisciplinary, incorporating elements of CHEK2, Fanconi anemia, FANCM and Gene mutation.
Her biological study spans a wide range of topics, including Genetic counseling and Complex segregation analysis.
Her Oncology research includes elements of Serous fluid, Cancer Etiology, Cancer Family, Ovarian tumor and Penetrance.
Her Cancer research integrates issues from Germline mutation, PALB2 and Germline.
Susan J. Ramus has researched Carcinoma in several fields, including Histology, Tissue microarray, Cohort and Adenocarcinoma.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
